Physician profile
Heather Cha
NPI 1952566978
$15,821.11
in general payments reported to CMS, 2019-2025
28 companies · $5,140 in 2025
The $5,140 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $118 · 2021: $287 · 2022: $121 · 2023: $543 · 2024: $9,613 · 2025: $5,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,375 · Food and Beverage: $3,733 · Travel and Lodging: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,375.00 |
| Food and Beverage | $3,733.05 |
| Travel and Lodging | $2,187.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,407.58 | 2023-2025 | Watchman Access System, Watchman Flx, Watchman |
| Medtronic, INC. | $519.12 | 2025 | Symplicity G3, Protege Rx |
| Abbott Laboratories | $469.06 | 2021-2025 | Cardiomems, Emboshield Nav6 |
| E.R. Squibb & Sons, L.L.C. | $339.99 | 2023-2025 | Camzyos, Eliquis |
| Amgen INC. | $291.52 | 2023-2025 | Repatha, Repatha |
| Abiomed | $283.45 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $246.34 | 2023-2025 | Verquvo, Winrevair |
| Novartis Pharmaceuticals Corporation | $198.20 | 2023-2025 | |
| Pfizer INC. | $121.85 | 2024-2025 | |
| Asahi Intecc USA, INC. | $117.56 | 2020 | |
| Philips North America LLC | $100.43 | 2023-2025 | (Ck4) Mcot, Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $97.19 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $88.08 | 2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $83.52 | 2024-2025 | Assure Wcd |
| Novo Nordisk INC | $70.44 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $56.87 | 2024 | Nexletol |
| Astrazeneca Pharmaceuticals Lp | $51.79 | 2023-2024 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $50.95 | 2024 | Arcalyst |
| Cvrx, INC. | $36.68 | 2024 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $32.59 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.89 | 2023-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $23.03 | 2024 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $21.34 | 2024 | Onpattro |
| Azurity Pharmaceuticals, INC. | $19.78 | 2024 | Edarbi |
| Bard Peripheral Vascular, INC. | $17.72 | 2025 | Covera |
| Sanofi-Aventis U.S. LLC | $17.18 | 2024 | |
| Impulse Dynamics (USA) INC. | $14.50 | 2023 | Optimizer |
| Scpharmaceuticals INC. | $13.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Cha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.